Clinical Trials
Clinical Trial Detail
Return to search results.
A Study of Brentuximab Vedotin in Patients With CD30-positive Non-Hodgkin Lymphoma
Complete title: A phase 2 study of brentuximab vedotin in relapsed or refractory CD30-positive non-Hodgkin lymphoma (NHL)
| Research Study Number | 20110853 | ||
| Principal Investigator | Andrei Shustov, MD | ||
| Phase | II |
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
- Genders Eligible for Study: Both
- Histologically-confirmed CD30-positive NHL
- Relapsed or refractory disease following at least 1 prior systemic therapy
- Measurable disease of at least 1.5 cm as documented by CT
- ECOG performance status less than or equal to 2
Other eligibility criteria may apply.
Exclusions (conditions that would prevent participation in this study)
- Current diagnosis of systemic or cutaneous anaplastic large cell lymphoma or mycosis fungoides
- B cell lymphoma previously treated with only single-agent rituximab or corticosteroids as monotherapy
- Known cerebral/meningeal disease
Other exclusion criteria may apply.
|
Keywords
Hematologic Malignancies; Lymphoma; Non-Hodgkin's Lymphoma (NHL)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
- Talk to your health care providers first before making decisions about your health care.
- Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.
- Diseases
& Research
- Treatment
& Support
- About Us
- Labs &
Projects
- Events &
Community Programs
- How You
Can Help Us
The Hutchinson Center's world-renowned scientists are discovering new ways to detect, prevent and treat cancer, HIV/AIDS and many other diseases.
- License Our Discoveries
The Hutchinson Center's world-renowned researchers work together to pursue lifesaving therapies that will help eliminate cancer and related diseases.
The Hutchinson Center's clinical research breakthroughs are delivered to patients through our treatment arm, the Seattle Cancer Care Alliance. This collaboration combines the strengths of the Hutchinson Center, UW Medicine and Seattle Children's.
You can help eliminate cancer and related diseases by attending Hutchinson Center events and participating in our other fundraising and community efforts.
- Divisions
The Hutchinson Center's pioneering researchers push the boundaries of science to find new ways to prevent, detect and treat cancer and related diseases.
Private support is critical to fund new research ideas and innovations, accelerating our ability to make lifesaving discoveries.
